Summary:
- Researchers have identified that Vitamin B12 supplementation significantly enhances the anti-tumor activity of CD8+ T cells in mouse models of glioma.
- The study demonstrates that B12 aids in the metabolic reprogramming of these immune cells, potentially offering a novel therapeutic strategy to improve the efficacy of cancer immunotherapies for brain tumors.